Serum proteome analysis in patients with rheumatoid arthritis receiving therapy with etanercept, a chimeric tumor necrosis factor-alpha receptor

International Journal of Rheumatic Diseases

Volumn 15, Issue 5, 2012, Pages 486-495

  Yanagida, Mitsuaki ^a   Jung, Giman ^b   Tanaka, Yoshinori ^b   Sone, Saburo ^b   Fujishiro, Maki ^a   Ikeda, Keigo ^a,c   Nozawa, Kazuhisa ^d   Kaneko, Hiroshi ^e   Takasaki, Yoshinari ^d   Ogawa, Hideoki ^a   Takamori, Kenji ^a   Sekigawa, Iwao ^a,c  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TORAY INDUSTRIES INC   (Japan)

^c JUNTENDO UNIVERSITY URAYASU HOSPITAL   (Japan)

^d JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e National Center for Global Health and Medicine   (Japan)

Author keywords

Etanercept; Proteomics; Rheumatoid arthritis; Tumor necrosis factor

Indexed keywords

BETA ACTIN; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 2; COLLAGEN TYPE 11; COLLAGEN TYPE 11 ALPHA 1 ISOFORM A PREPROTEIN; COLLAGEN TYPE 2; COLLAGEN TYPE 2 ALPHA 1; COLLAGEN TYPE 5; COLLAGEN TYPE 5 ALPHA 1 PREPROTEIN; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR D; CONNECTIVE TISSUE GROWTH FACTOR; ETANERCEPT; FIBULIN 5; GRANULIN PRECURSOR; GROWTH FACTOR; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR; GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR BETA; KININOGEN; KININOGEN 1 ISOFORM 2; METHOTREXATE; PREDNISOLONE; PROENKEPHALIN; PROSTAGLANDIN D SYNTHASE; PROTEOGLYCAN; PROTEOGLYCAN 4 ISOFORM A; RECOMBINANT SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CARTILAGE; CLINICAL ARTICLE; COMPARATIVE STUDY; EXTRACELLULAR MATRIX; FEMALE; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR WEIGHT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; TREATMENT RESPONSE;

ADULT; ARTHRITIS, RHEUMATOID; COMPLEMENT FACTOR D; ENKEPHALINS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTRAMOLECULAR OXIDOREDUCTASES; KININOGENS; LIPOCALINS; MIDDLE AGED; PROTEIN PRECURSORS; PROTEOGLYCANS; PROTEOME; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 84867917006     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2012.01816.x     Document Type: Article

References (32)

1. Maini RN, Elliott MJ, Brennan FM et al. (1995) Monoclonal anti-TNF alpha antibody as a probe of pathogenesis and therapy of rheumatoid disease. Immunol Rev 144, 195-223.
2. Kempeni J (1999) Preliminary results of early clinical trials with the fully human anti-TNFalpha monoclonal antibody D2E7. Ann Rheum Dis 58(Suppl 1), I70-2.
3. Mohler KM, Torrance DS, Smith CA et al. (1993) Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol 151, 1548-61.
4. Mihara M, Nishimoto N, Ohsugi Y (2005) The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody. Expert Opin Biol Ther 5, 683-90.
5. Dall'Era M, Davis J (2004) CTLA4Ig: a novel inhibitor of costimulation. Lupus 13, 372-6.
6. Moreland LW, Baumgartner SW, Schiff MH et al. (1997) Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 337, 141-7.
7. Scallon BJ, Moore MA, Trinh H, Knight DM, Ghrayeb J (1995) Chimeric anti-TNF-alpha monoclonal antibody cA2 binds recombinant transmembrane TNF-alpha and activates immune effector functions. Cytokine 7, 251-9.
8. Sekigawa I, Yanagida M, Iwabuchi K et al. (2008) Protein biomarker analysis by mass spectrometry in patients with rheumatoid arthritis receiving anti-tumor necrosis factor-alpha antibody therapy. Clin Exp Rheumatol 26, 261-7.
9. Nozawa K, Fujishiro M, Kawasaki M et al. (2009) Connective tissue growth factor promotes articular damage by increased osteoclastogenesis in patients with rheumatoid arthritis. Arthritis Res Ther 11, R174.
10. De Franceschi L, Bosello S, Scambi C et al. (2011) Proteome analysis of biological fluids from autoimmune-rheumatological disorders. Proteomics Clin Appl 5, 78-89.
11. Dwivedi RC, Dhindsa N, Krokhin OV, Cortens J, Wilkins JA, El-Gabalawy HS (2009) The effects of infliximab therapy on the serum proteome of rheumatoid arthritis patients. Arthritis Res Ther 11, R32.
12. Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31, 315-24.
13. Steinbrocker O, Traeger CH, Batterman RC (1949) Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc 140, 659-62.
14. Prevoo ML, van 'tHof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38, 44-8.
15. Tanaka Y, Akiyama H, Kuroda T et al. (2006) A novel approach and protocol for discovering extremely low-abundance proteins in serum. Proteomics 6, 4845-55.
16. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20, 3551-67.
17. Washburn MP, Ulaszek RR, Yates JR III, (2003) Reproducibility of quantitative proteomic analyses of complex biological mixtures by multidimensional protein identification technology. Anal Chem 75, 5054-61.
18. Liu H, Sadygov RG, Yates JR III, (2004) A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 76, 4193-201.
19. Ishihama Y, Oda Y, Tabata T et al. (2005) Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 4, 1265-72.
20. Tirumalai RS, Chan KC, Prieto DA, Issaq HJ, Conrads TP, Veenstra TD (2003) Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2, 1096-103.
21. Anderson NL, Anderson NG (2002) The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1, 845-67.
22. Eguchi Y (2006) Prostaglandin D (PGD) 2 and Rheumatoid Arthritis (language in Japanese). In: Shichikawa K (ed) Riumachi-byo seminar, 17th edn, pp 163-7. Nagai Shoten Press, Osaka, Japan.
23. Sharma JN, Zeitlin IJ, Brooks PM, Dick WC (1976) A novel relationship between plasma kininogen and rheumatoid. Agents Actions 6, 148-53.
24. Matsuda A, Suzuki Y, Honda G et al. (2003) Large-scale identification and characterization of human genes that activate NF-kappaB and MAPK signaling pathways. Oncogene 22, 3307-18.
25. Knuefermann P, Chen P, Misra A, Shi SP, Abdellatif M, Sivasubramanian N (2002) Myotrophin/V-1, a protein up-regulated in the failing human heart and in postnatal cerebellum, converts NFkappa B p50-p65 heterodimers to p50-p50 and p65-p65 homodimers. J Biol Chem 277, 23888-97.
26. Jay GD, Tantravahi U, Britt DE, Barrach HJ, Cha CJ (2001) Homology of lubricin and superficial zone protein (SZP): products of megakaryocyte stimulating factor (MSF) gene expression by human synovial fibroblasts and articular chondrocytes localized to chromosome 1q25. J Orthop Res 19, 677-87.
27. Elsaid KA, Fleming BC, Oksendahl HL et al. (2008) Decreased lubricin concentrations and markers of joint inflammation in the synovial fluid of patients with anterior cruciate ligament injury. Arthritis Rheum 58, 1707-15.
28. Elsaid KA, Jay GD, Chichester CO (2007) Reduced expression and proteolytic susceptibility of lubricin/superficial zone protein may explain early elevation in the coefficient of friction in the joints of rats with antigen-induced arthritis. Arthritis Rheum 56, 108-16.
29. Anakwe OO, Gerton GL (1990) Acrosome biogenesis begins during meiosis: evidence from the synthesis and distribution of an acrosomal glycoprotein, acrogranin, during guinea pig spermatogenesis. Biol Reprod 42, 317-28.
30. Guo F, Lai Y, Tian Q, Lin EA, Kong L, Liu C (2010) Granulin-epithelin precursor binds directly to ADAMTS-7 and ADAMTS-12 and inhibits their degradation of cartilage oligomeric matrix protein. Arthritis Rheum 62, 2023-36.
31. Nakayamada S, Kurose H, Saito K, Mogami A, Tanaka Y (2005) Small GTP-binding protein Rho-mediated signaling promotes proliferation of rheumatoid synovial fibroblasts. Arthritis Res Ther 7, R476-84.
32. Hueber W, Tomooka BH, Batliwalla F et al. (2009) Blood autoantibody and cytokine profiles predict response to anti-tumor necrosis factor therapy in rheumatoid arthritis. Arthritis Res Ther 11, R76.